These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prevention of Periprocedural Myocardial Injury During Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease. Ito S; Kitakaze M Circ J; 2018 Jun; 82(7):1746-1748. PubMed ID: 29769462 [No Abstract] [Full Text] [Related]
6. Percutaneous coronary intervention for poor coronary microcirculation reperfusion of patients with stable angina pectoris. Li JS; Zhao XJ; Ma BX; Wang Z J Biol Regul Homeost Agents; 2016; 30(3):733-741. PubMed ID: 27655490 [TBL] [Abstract][Full Text] [Related]
7. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina. Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922 [TBL] [Abstract][Full Text] [Related]
8. Percutaneous Coronary Intervention Without Onsite Cardiac Surgery: Ready for Take-Off? Pande AN; Jacobs AK J Am Coll Cardiol; 2015 Jul; 66(4):373-5. PubMed ID: 26205594 [No Abstract] [Full Text] [Related]
9. Comparison of clinical outcomes according to presentation of angina pectoris versus acute myocardial infarction in patients who underwent a percutaneous coronary intervention with a drug-eluting stent. Seo SM; Kim TH; Koh YS; Her SH; Shin DI; Park HJ; Kim PJ; Park CS; Lee JM; Kim DB; Kim HY; Chang K; Yoo KD; Jeon DS; Chung WS; Seung KB; Coron Artery Dis; 2016 Mar; 27(2):143-50. PubMed ID: 26693807 [TBL] [Abstract][Full Text] [Related]
10. Percutaneous coronary intervention versus coronary artery bypass graft for stable angina: meta-regression of randomized trials. D'Ascenzo F; Barbero U; Moretti C; Palmerini T; Della Riva D; Mariani A; Omedè P; DiNicolantonio JJ; Biondi-Zoccai G; Gaita F Contemp Clin Trials; 2014 May; 38(1):51-8. PubMed ID: 24657881 [TBL] [Abstract][Full Text] [Related]
11. Relationship between subclinical cardiac troponin I elevation and culprit lesion characteristics assessed by optical coherence tomography in patients undergoing elective percutaneous coronary intervention. Lee T; Murai T; Yonetsu T; Suzuki A; Hishikari K; Kanaji Y; Matsuda J; Araki M; Niida T; Isobe M; Kakuta T Circ Cardiovasc Interv; 2015 Apr; 8(4):. PubMed ID: 25829198 [TBL] [Abstract][Full Text] [Related]
12. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial. Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058 [TBL] [Abstract][Full Text] [Related]
14. Malondialdehyde-modified low-density lipoprotein is a predictor of cardiac events in patients with stable angina on lipid-lowering therapy after percutaneous coronary intervention using drug-eluting stent. Ito T; Fujita H; Tani T; Ohte N Atherosclerosis; 2015 Apr; 239(2):311-7. PubMed ID: 25682029 [TBL] [Abstract][Full Text] [Related]
15. Effect of estimated glomerular filtration rate on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention. Vatankulu MA; Murat SN; Demircelik B; Turfan M; Sonmez O; Duran M; Bacaksiz A; Ornek E; Tasal A; Goktekin O Ren Fail; 2013 Aug; 35(7):931-5. PubMed ID: 23803143 [TBL] [Abstract][Full Text] [Related]
16. Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting Stent. Cho KI; Ann SH; Singh GB; Her AY; Shin ES PLoS One; 2015; 10(7):e0133934. PubMed ID: 26207383 [TBL] [Abstract][Full Text] [Related]
17. Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease. Gössl M; Faxon DP; Bell MR; Holmes DR; Gersh BJ Circ Cardiovasc Interv; 2012 Aug; 5(4):597-604. PubMed ID: 22896575 [No Abstract] [Full Text] [Related]
18. What is the place of percutaneous coronary intervention in the management of stable angina? Escobar C; Barrios V Hellenic J Cardiol; 2012; 53(3):249-50. PubMed ID: 22653252 [No Abstract] [Full Text] [Related]
19. Percutaneous coronary intervention for stable angina in ORBITA - Authors' reply. Francis DP; Al-Lamee R Lancet; 2018 Jul; 392(10141):28-30. PubMed ID: 30047396 [No Abstract] [Full Text] [Related]
20. CYP2C19 poor metabolizer is associated with clinical outcome of clopidogrel therapy in acute myocardial infarction but not stable angina. Kim HS; Chang K; Koh YS; Park MW; Choi YS; Park CS; Oh M; Kim EY; Shon JH; Shin JG; Seung KB Circ Cardiovasc Genet; 2013 Oct; 6(5):514-21. PubMed ID: 24019397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]